UY33788A - Derivados de arilsulfonamida para la prevención o el tratamiento de trastornos oftalmológicos específicos - Google Patents
Derivados de arilsulfonamida para la prevención o el tratamiento de trastornos oftalmológicos específicosInfo
- Publication number
- UY33788A UY33788A UY0001033788A UY33788A UY33788A UY 33788 A UY33788 A UY 33788A UY 0001033788 A UY0001033788 A UY 0001033788A UY 33788 A UY33788 A UY 33788A UY 33788 A UY33788 A UY 33788A
- Authority
- UY
- Uruguay
- Prior art keywords
- derivatives
- arilsulfonamide
- prevention
- treatment
- specific
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La invención se dirige al uso terapéutico de derivados de arilsulfonamida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10306381 | 2010-12-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY33788A true UY33788A (es) | 2012-07-31 |
Family
ID=43567690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001033788A UY33788A (es) | 2010-12-09 | 2011-12-09 | Derivados de arilsulfonamida para la prevención o el tratamiento de trastornos oftalmológicos específicos |
Country Status (15)
Country | Link |
---|---|
US (1) | US20130315903A1 (es) |
EP (1) | EP2648712B1 (es) |
JP (1) | JP2013544871A (es) |
CN (1) | CN103402507B (es) |
AR (1) | AR084194A1 (es) |
AU (1) | AU2011340494B2 (es) |
BR (1) | BR112013014379A2 (es) |
CA (1) | CA2820124A1 (es) |
ES (1) | ES2559223T3 (es) |
HK (1) | HK1186383A1 (es) |
MX (1) | MX2013006527A (es) |
RU (1) | RU2583929C2 (es) |
UY (1) | UY33788A (es) |
WO (1) | WO2012076685A1 (es) |
ZA (1) | ZA201304121B (es) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0954305B9 (en) * | 1996-02-26 | 2010-08-04 | Advanced Research & Technology Institute | Use of carbonic anhydrase inhibitors for treating macular edema |
FR2840897B1 (fr) * | 2002-06-14 | 2004-09-10 | Fournier Lab Sa | Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique |
US20080153819A1 (en) * | 2006-12-21 | 2008-06-26 | Bingaman David P | Methods for treating macular edema and pathologic ocular angiogenesis using a neuroprotective agent and a receptor tyrosine kinase inhibitor |
TNSN08110A1 (en) * | 2008-03-11 | 2009-07-14 | Rekik Raouf Dr | Drug delivery to the anterior and posterior segment of the eye from drops |
RU2393824C1 (ru) * | 2009-04-14 | 2010-07-10 | Государственное учреждение "УФИМСКИЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ ГЛАЗНЫХ БОЛЕЗНЕЙ" Академии наук Республики Башкортостан (УфНИИ ГБ АН РБ) | Способ лечения макулярных отеков различного генеза |
AR084193A1 (es) * | 2010-12-09 | 2013-04-24 | Fovea Pharmaceuticals | Dosificaciones de derivados de arilsufonamida |
-
2011
- 2011-12-07 AR ARP110104582A patent/AR084194A1/es not_active Application Discontinuation
- 2011-12-09 AU AU2011340494A patent/AU2011340494B2/en not_active Ceased
- 2011-12-09 UY UY0001033788A patent/UY33788A/es unknown
- 2011-12-09 MX MX2013006527A patent/MX2013006527A/es active IP Right Grant
- 2011-12-09 BR BR112013014379A patent/BR112013014379A2/pt not_active IP Right Cessation
- 2011-12-09 JP JP2013542559A patent/JP2013544871A/ja active Pending
- 2011-12-09 EP EP11794722.6A patent/EP2648712B1/en active Active
- 2011-12-09 ES ES11794722.6T patent/ES2559223T3/es active Active
- 2011-12-09 US US13/992,314 patent/US20130315903A1/en not_active Abandoned
- 2011-12-09 RU RU2013131281/15A patent/RU2583929C2/ru not_active IP Right Cessation
- 2011-12-09 CN CN201180065972.3A patent/CN103402507B/zh not_active Expired - Fee Related
- 2011-12-09 WO PCT/EP2011/072306 patent/WO2012076685A1/en active Application Filing
- 2011-12-09 CA CA2820124A patent/CA2820124A1/en not_active Abandoned
-
2013
- 2013-06-05 ZA ZA2013/04121A patent/ZA201304121B/en unknown
- 2013-12-11 HK HK13113781.1A patent/HK1186383A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2012076685A1 (en) | 2012-06-14 |
CA2820124A1 (en) | 2012-06-14 |
AR084194A1 (es) | 2013-04-24 |
US20130315903A1 (en) | 2013-11-28 |
EP2648712A1 (en) | 2013-10-16 |
RU2583929C2 (ru) | 2016-05-10 |
AU2011340494B2 (en) | 2015-05-14 |
HK1186383A1 (en) | 2014-03-14 |
BR112013014379A2 (pt) | 2016-09-27 |
EP2648712B1 (en) | 2015-10-21 |
CN103402507B (zh) | 2016-02-17 |
RU2013131281A (ru) | 2015-01-20 |
ZA201304121B (en) | 2014-08-27 |
JP2013544871A (ja) | 2013-12-19 |
MX2013006527A (es) | 2014-06-11 |
ES2559223T3 (es) | 2016-02-11 |
CN103402507A (zh) | 2013-11-20 |
AU2011340494A1 (en) | 2013-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013015855A2 (pt) | composto, uso de um composto, métodos de prevenção, tratamento, melhora ou profilaxia de distúrbios fisiológicos ou doenças, e de tratamento ou melhora de indicações cosméticas, e, composição farmacêutica. | |
BR112013015859A2 (pt) | composto, uso de um composto, métodos de prevenção, tratamento, melhora ou profilaxia de distúrbios fisiológicos ou doenças, e de tratamento ou melhora de indicações cosméticas, e, composição farmacêutica | |
ECSP14017269A (es) | Compuestos para tratar la atrofia muscular espinal | |
GT200900230A (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso | |
GT201300209A (es) | Compuestos y composiciones como inhibidores de la trk | |
MX2014005304A (es) | Biaril eter sulfonamidas y su uso como agentes terapeuticos. | |
ECSP12012310A (es) | 5-fluoro-1h-pirazolopiridinas sustituidas y su uso | |
CR20130464A (es) | Inhibidores sustituidos de acetil-coa carboxilasa | |
CR11684A (es) | Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa | |
EA201300471A1 (ru) | Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3 | |
SMT201200017B (it) | Nuovi antagonisti P2X7R e il loro uso. | |
EA201491854A1 (ru) | Асимметрический синтез соединений спирооксиндола, полезных в качестве терапевтических средств | |
GT201600027A (es) | Inhibidores de rorc2 y sus métodos de uso | |
UY35747A (es) | Derivados sustituidos de fenilalanina | |
BR112013015877A2 (pt) | composto, uso de um composto, métodos de prevenção. tratamento, melhora ou profilaxia de distúrbios fisiológicos ou doenças, e de tratamento ou melhora de indicações cosméticas, e, composição farmacêutica. | |
BR112012032721A2 (pt) | compostos heterocíclicos, sua preparação e sua aplicação terapêutica | |
UY33530A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias | |
UY35746A (es) | Derivados de fenilalanina sustituidos | |
UY35745A (es) | Derivados sustituidos de fenilalanina | |
BR112012015386B8 (pt) | composição oftálmica tópica | |
TR201004464A2 (tr) | Kemik erimesi için formülasyon. | |
CY1116158T1 (el) | Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3 | |
EA201390398A1 (ru) | Арилсульфонамиды для лечения заболеваний цнс | |
BR112014030288A8 (pt) | composição farmacêutica, uso da mesma, e, uso de metanossulfonilacetonitrila | |
PH12015501210A1 (en) | Use of pidotimod to treat psoriasis |